Clarivate PLC (CLVT)

Clarivate Plc's stock (CLVT) has experienced a notable decline over the past year, with a closing stock price of $2.16 as of February 6, 2026, significantly decreased from its 52-week high of $5.16. The stock was down 15.63% over the past 30 days and down 49.47% over the past 12 months as of January 28, 2026. Key events impacting the stock price include the Q3 2025 earnings report with revenues of $623.1 million and a net loss of $28.3 million, the Q4 and full year 2024 results with decreased revenue and exploration of strategic alternatives, the Q1 2025 earnings report with revenues of $593.7 million and a net loss of $103.9 million, the full redemption of Senior Secured Notes, and the upcoming Q4 and full year 2025 results.

A significant portion of Clarivate Plc's revenue is derived from subscription-based services, providing a steady income stream due to reliance on annual or multi-year subscriptions. While the company also generates revenue from consulting, professional services, product sales, licensing, and transactional services, the subscription-first focus aims for improved renewal rates and higher usage, suggesting a relatively stable demand profile rather than pronounced seasonality. No explicit information indicating significant demand seasonality for Clarivate's products and services was found.

Clarivate Plc is a British-American publicly traded analytics company providing transformative intelligence through data, insights, analytics, workflow solutions, and expert services, operating in the Industrials sector, specifically within Research and Consulting Services, and serving diverse industries such as academia, government, life sciences, healthcare, professional services, consumer goods, manufacturing, and technology. Clarivate offers products and services such as the Web of Science Platform for scholarly research, ProQuest One Academic for libraries, Ex Libris library services platforms, Cortellis intelligence solutions for life sciences, Medtech 360 market insights for medical technology, a Real-World Data Product for patient care insights, IPfolio and FoundationIP cloud-based IP management platforms, Derwent Patent Search for patent analytics, CompuMark trademark solutions, Journal Citation Reports for journal impact factors, and EndNote reference management tools.

Clarivate Plc has a significant global presence, operating in over 40 countries with headquarters in Philadelphia, United States, and London, United Kingdom, and operations spanning the Americas, APAC, and Europe/Middle East/Africa regions.

Clarivate Plc has a strong brand reputation, recognized for its reliability, accuracy, and comprehensive research and analytics services, and is considered a trusted source for authoritative news and analysis. The company emphasizes its investment in content, workflows, and an AI-first mindset, contributing to its trusted reputation as a global leader. No specific negative events significantly impacting Clarivate Plc's brand reputation have been identified, and the company actively engages in thought leadership and highlights its commitment to sustainability.

Clarivate Plc has a significant number of institutional owners and shareholders, including Leonard Green & Partners, L.P., Exor N.V., Clarkston Capital Partners, LLC, Impactive Capital LP, Partners Group Holding AG, FIL Ltd, Dimensional Fund Advisors Lp, BlackRock, Inc., Citadel Advisors Llc, CFSMX - Clarkston Partners Fund Founders Class, LSV Asset Management, Fideuram Intesa Sanpaolo Private Banking S.P.A., Generation Investment Management LLP, and Janus Henderson Group PLC.